Phylogenomics and antimicrobial resistance of the leprosy bacillus Mycobacterium leprae.
Benjak A, Avanzi C, Singh P, Loiseau C, Girma S, Busso P, et al.. Nature communications. 2018; 9(1):352.
Mycobacterium leprae- specific antibodies in multibacillary leprosy patients decrease during and after treatment with either the regular 12 doses multi-drug therapy (MDT) or the uniform 6 doses MDT.
Hungria EM, Bührer-Sékula S, Oliveira RM, Aderaldo LC, Pontes MA, Cruz R, et al.. Frontiers in immunology. 2018;
Specific antibodies in multibacillary leprosy patients decrease during and after treatment with either the regular 12 doses multidrug therapy (MDT) or the uniform 6 doses MDT.
Hungria EM, Bührer-Sékula S, Oliveira RM, Aderaldo LC, Pontes M, Cruz R, et al.. Frontiers in immunology. 2018; 9915.
Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases.
Stefani MM, Avanzi C, Bührer-Sékula S, Benjak A, Loiseau C, Singh P, et al.. PLoS neglected tropical diseases. 2017; 11(6):e0005598.
Anti-PGL-1 Positivity as a Risk Marker for the Development of Leprosy among Contacts of Leprosy Cases: Systematic Review and Meta-analysis.
Penna M, Penna GO, Iglesias PC, Natal S, Rodrigues LC. PLoS neglected tropical diseases. 2016; 10(5):e0004703.
Commitment to reducing disability: the Brazilian experience.
Oliveira LM, Grossi AM, Oliveira CF, Sena SA, Daxbacher E, Penna GO. Leprosy review. 2010; 81(4):342-5.
Trend of case detection and leprosy elimination in Brazil.
Penna ML, Penna GO. Tropical medicine & international health : TM & IH. 2007; 12(5):647-50.
Role of dermatologists in leprosy elimination and post-elimination era: the Brazilian contribution.
Oliveira M, Penna GO, Telhari S. Leprosy review. 2007; 78(1):17-21.
Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.